"Its history includes some of the major scientific advances of the nineteenth and twentieth centuries…" On 18th May 1999, Sanofi and Synthélabo officially came together in Paris, France to form ...

« Tarifs douaniers sont les deux plus beaux mots du dictionnaire », a déclaré publiquement Donald Trump en octobre 2024 en ...

Interrogé par Medscape France, le Dr Fabrice André (Institut ... Son institution a reçu des financements pour ses recherches de Genentech/Roche, Pfizer, Puma, Sanofi-Aventis, et Bristol-Myers Squibb.

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank ...

Sanofi (SNYNF, SNY) said the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Sanofi : approbation pour le Sarclisa en Chine 13/01 AO Sanofi : Sarclisa approuvé dans le myélome multiple en Chine 13/01 CF Sanofi obtient une approbation pour le Sarclisa en Chine 13/01 RE ...

Sanofi est le 1er groupe pharmaceutique européen ... La répartition géographique du CA est la suivante : France (5,5%), Europe (18,6%), Etats-Unis (43%), Amérique du Nord (1,6%) et autres ...